We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Implantable Ultrasound Biosensor Monitors pH Fluctuations

By MedImaging International staff writers
Posted on 05 May 2020
Print article
Image: Coated Silica cores change in response to Ph, which can be detected by ultrasound (Photo courtesy of Monash University)
Image: Coated Silica cores change in response to Ph, which can be detected by ultrasound (Photo courtesy of Monash University)
A new study reveals how a small insertable biosensor emits diagnostic signals that can be detected by common ultrasound scanners.

Developed at Monash University (Melbourne, Australia) and the Baker IDI Heart and Diabetes Institute (Melbourne, Australia), the solid nanoparticle sensors are designed to alter their stiffness in response to pH changes. The biosensor transmits the measured data by then modifying ultrasound contrast scanning signals. The sensors are made of a Silica (SiO2) core coated with pH-responsive polymethacrylic acid (PMASH) in a layer-by-layer approach, supervised via transmission electron and confocal laser scanning microscopy. The sensor is then covered in a porous organosilica shell.

The researchers subsequently confirmed the pH-dependent shrinkage and swelling of the PMASH layer, successfully demonstrating that reduction in pH below healthy physiological levels resulted in significant increases in ultrasound contrast, as measured in gel phantoms, mouse cadaver tissue, and in live mice. According to the researchers, more complex markers, such as oxygen (as an indicator of stroke injury) or disease-related proteins might also be detected in the future using similar ultrasound biomarkers. The study was published on March 23, 2020, in ACS Sensors.

“Our goal is to give clinicians the power of being able to have a patient sit in a chair and, as they are infusing the drugs, use commonly available ultrasound to monitor drug levels or organ response in real-time, adjusting dosages as a function of the patient’s needs,” said senior author Simon Corrie, PhD, of the department of chemical engineering at Monash University. “The technology has been tested in an animal model to detect changes in pH levels. We hope to now continue testing in animal models to determine whether it can accurately monitor rapidly changing pH levels, initially focusing on cancer and stroke.”

While a range of biosensors have been designed for optical, photoacoustic, and magnetic resonance imaging (MRI) modalities, various technical challenges have hindered the development of ultrasound biosensors, even though ultrasound is widely available, portable, safe, and capable of both surface and deep tissue imaging.

Related Links:
Monash University
Baker IDI Heart and Diabetes Institute


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
MRI System
uMR 588
New
Ultrasound Doppler System
Doppler BT-200

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.